| A Cure for Swelling Drug Prices: Competition A2 While the U.S. health care system is notoriously costly, prices of generic drugs have actually been falling. Price spikes like EpiPen reflect a lack of competition that can be curbed by allowing generics approved abroad to be sold in the U.S., Greg Ip writes. |
0 Response to "Today's Paper: Asia"
Posting Komentar